Acquired factor VIII inhibitor in a patient with malignant lymphoma.
D001772:Blood Cell Count; D001778:Blood Coagulation Disorders / Q000150:complications*; D001780:Blood Coagulation Tests; D001798:Blood Proteins / Q000032:analysis; D001806:Blood Urea Nitrogen; D001853:Bone Marrow / Q000473:pathology; D001854:Bone Marrow Cells; D003404:Creatinine / Q000097:blood; D003520:Cyclophosphamide / Q000627:therapeutic use; D005169:Factor VIII / Q000037:antagonists & inhibitors* / Q000627:therapeutic use; D006400:Hematocrit; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000097:blood* / Q000188:drug therapy / Q000276:immunology; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D013921:Thrombocytopenia / Q000150:complications
D001798:Blood Proteins; D006454:Hemoglobins; D003520:Cyclophosphamide; D005169:Factor VIII; D003404:Creatinine; D011241:Prednisone